U S Physical Therapy Inc Revenue per Employee (USPH), current and historic results, rankings and more, quarterly fundamentals - CSIMarket
CSIMarket
 


U S Physical Therapy Inc  (NYSE: USPH)
 

U S Physical Therapy Inc's Revenue per Employee

Quarterly Results, Trends, Rankings, Statistics, Cumulative Sales


With a revenue increase of 8.47% in the second quarter 2026, year on year to cumulative value of $812 million, U S Physical Therapy Inc's revenue per employee grew on a trailing twelve months basis to $ 111,352, this marks a new company high.
Within the Healthcare sector Employees of 461 other companies have achieved higher revenue per employee. While U S Physical Therapy Inc's total ranking has deteriorated compared to the previous quarter from 2940 to 3266. U S Physical Therapy Inc has 7,294 employees.


What is Sales per Employee Ratio?







USPH Revenue per Employee (Jun 30 2026)
II. Quarter
(Mar 31 2026)
I. Quarter
(Dec 31 2025)
IV. Quarter
(Sep 30 2025)
III. Quarter
(Jun 30 2025)
II. Quarter
Y / Y Revenue Change 8.47 % 7.89 % 12.35 % 17.32 % 18.04 %
Sales per Employee (TTM) $ 111,352 109,061 107,073 104,019 100,029
USPH's Total Ranking # 3266 # 2940 # 1894 # 2380 # 2602
Seq. Revenue Change 7.95 % -2.19 % 2.84 % -0.11 % 7.38 %


Revenue per Employee Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 150
Healthcare Sector # 462
Overall Market # 3266

Revenue per Employee Statistics
High Average Low
$ 111,352 $ 64,295 $ 31,002
(Jun 30 2026)   (Mar 31 2023)



Financial Statements
U S Physical Therapy Inc's Revenue MRQ $ 214 Millions Visit USPH's Income Statement
U S Physical Therapy Inc's Revenues TTM $ 812 Millions Visit USPH's aggregate revenue growth
What are USPH's Sales? Visit USPH's Sales by Segment




Other Ratios
U S Physical Therapy Inc's Income per Employee
Employees in Medical Equipment & Supplies
Medical Equipment & Supplies Industry Revenue per Employee Trends and Statistics
Healthcare Sector Revenue per Employee Statistics
Revenue per Employee Trends for overall market
USPH's Revenue per Employee versus Medical Equipment & Supplies Industry, Healthcare Sector and total Market
Highest Ranking Revenue per Employee
Lowest Ranking Revenue per Employee
Revenue per Employee for USPH's Competitors
Revenue per Employee for USPH's Suppliers
Revenue per Employee for USPH's Customers

You may also want to know
USPH's Sales Growth Rates USPH's Pe Price to earnings ratio USPH's Receivables Turnover Ratio USPH's Stock Quote
USPH's Net Income Growth Rates USPH's Ps Price to Sales ratio USPH's Sales per Employee USPH's Asset Turnover Ratio
USPH's Net Margin USPH's Pb Price to Book ratio USPH's Financial Strength Ratios USPH's Dividend Payout Ratio
Date modified: 2026-09-26T07:12:56+00:00




Companies with similar Revenue per Employee for 12 months ending Jun 30 2026, within Healthcare Sector Revenue per Employee Revenue 12 months ending Jun 30 2026Number of Employees Jun 30 2026
Arcus Biosciences Inc   194,675.54 $ 117.000  Million 601 
Gyre Therapeutics Inc   193,176.38 $ 119.383  Million 618 
Tao Synergies Inc   193,124.75 $ 0.772  Million 4 
Safe Pro Group Inc   192,088.60 $ 2.881  Million 15 
Monte Rosa Therapeutics Inc   191,513.33 $ 28.727  Million 150 
Fortrea Holdings Inc   187,167.83 $ 2,676.500  Million 14,300 
Agios Pharmaceuticals Inc   182,107.41 $ 98.338  Million 540 
Grail Inc   181,607.69 $ 165.263  Million 910 
Davita Inc   179,610.85 $ 14,009.646  Million 78,000 
Universal Health Services Inc   178,467.85 $ 18,114.487  Million 101,500 
Concentra Group Holdings Parent Inc   175,958.85 $ 2,287.465  Million 13,000 
Lineage Cell Therapeutics Inc   169,909.09 $ 13.083  Million 77 
Integer Holdings Corporation  167,511.00 $ 1,842.621  Million 11,000 
Bioage Labs Inc   167,016.13 $ 10.355  Million 62 
Retractable Technologies Inc  166,605.48 $ 33.488  Million 201 
Icu Medical Inc  166,153.69 $ 2,159.998  Million 13,000 
Prophase Labs Inc   165,789.47 $ 3.150  Million 19 
Bionexus Gene Lab Corp   164,556.89 $ 3.127  Million 19 
Chemed Corporation  164,126.30 $ 2,595.001  Million 15,811 
Humacyte Inc   163,445.65 $ 30.074  Million 184 
Stoke Therapeutics Inc   162,282.35 $ 27.588  Million 170 
Ocular Therapeutix Inc   160,166.15 $ 52.054  Million 325 
Seer Inc   159,744.44 $ 14.377  Million 90 
Intellia Therapeutics Inc   157,840.85 $ 59.506  Million 377 
Autolus Therapeutics Plc  155,689.66 $ 117.390  Million 754 
Hyperion Defi inc   155,633.22 $ 1.401  Million 9 
Marpai Inc  155,467.29 $ 16.635  Million 107 
National Vision Holdings Inc   154,774.39 $ 2,033.426  Million 13,138 
Medicinova Inc   153,413.50 $ 0.920  Million 6 
Hyperfine Inc   151,225.49 $ 15.425  Million 102 




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.